Congenital Cytomegalovirus Infection Clinical Trial
NCT number | NCT02710864 |
Other study ID # | CMV-EPI-003 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | January 2015 |
Est. completion date | March 2016 |
Verified date | May 2018 |
Source | Xiamen University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
The primary objectives of this study were to evaluate the incidence of congenital CMV infection in neonates, and assess the concordance of detecting congenital cytomegalovirus (CMV) infection in neonatal saliva and urine samples.
Status | Completed |
Enrollment | 1510 |
Est. completion date | March 2016 |
Est. primary completion date | March 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A to 14 Days |
Eligibility |
Inclusion Criteria: - Neonates aged 0 to 14 days - Neonates delivered in MCHHs of Xinmi City, Jiaxian County, Zhongmu County and Huli District Xiamen City Exclusion Criteria: - the parents of neonates not comply with our study |
Country | Name | City | State |
---|---|---|---|
China | Maternity and Child care of Jiaxian County | Pingdingshan | Henan |
China | Maternity and Child care of Huli District | Xiamen | Fujian |
China | Maternity and Child care of Xinmi City | Zhengzhou | Henan |
China | Maternity and Child care of Zhongmu County | Zhengzhou | Henan |
Lead Sponsor | Collaborator |
---|---|
Jun Zhang |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Number of cCMV infection in newborns | up to 5 months | ||
Secondary | the Kappa value of CMV prevalence between saliva and urine samples | up to 5 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01923636 -
Prognostic Value of Neonatal Markers for the Development of Neurosensorial Sequelae in Children Infected by Cytomegalovirus in Utero
|
N/A | |
Recruiting |
NCT03973359 -
Epidemiology and Prevention of Congenital HCMV in Immune Mothers. Congenital HCMV Infection Lombardy
|
N/A | |
Completed |
NCT02005822 -
Congenital Cytomegalovirus: Efficacy of Antiviral Treatment
|
Phase 3 | |
Completed |
NCT02139423 -
Diagnosis of Congenital CMV Infection in Neonates Who Failed Newborn Hearing Screening
|
N/A | |
Completed |
NCT02351102 -
Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During Pregnancy
|
Phase 2/Phase 3 | |
Withdrawn |
NCT02594566 -
Safety, Tolerability, and Immunogenicity of a Cytomegalovirus DNA Vaccine
|
Phase 1 | |
Active, not recruiting |
NCT05170269 -
Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion)
|
Phase 3 | |
Not yet recruiting |
NCT06118515 -
A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus
|
Phase 1 | |
Completed |
NCT02782988 -
Assesment of Olfactory Disorders and Performance of a New Olfactory Test in Children With Congenital CMV
|
||
Completed |
NCT02645396 -
A Cohort Study of Congenital Cytomegalovirus Infection Among Pregnant Women and Their Newborns in China
|
||
Terminated |
NCT01655212 -
Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial
|
Phase 3 | |
Completed |
NCT05754879 -
Diagnosis of Congenital Cytomegalovirus Infection in Newborn With Particular Risk
|
||
Terminated |
NCT03301415 -
Asymptomatic Congenital CMV Treatment
|
Phase 2 | |
Completed |
NCT01376778 -
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
|
Phase 3 |